Eugia Sez Private Limited
About Eugia Sez Private Limited
Data last updated:
Eugia Sez Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Eugia Pharma Specialities Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PTC148856. Its GSTIN is 36AACCW8850H1ZZ (Telangana).
The company has an authorised share capital of ₹360 Cr and a paid-up capital of ₹338 Cr. It was formerly known as Wytells Pharma Private Limited. It is led by directors including Madan Mohan Reddy Mettu and Vijay Natarajan.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹383 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹33.2 Cr (net margin -8.7%) and EBITDA of ₹11.9 Cr (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
The company has about 607 employees on its provident fund (EPFO) records.
Company details
Contact details
Eugia Sez Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eugia Sez Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eugia Sez is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eugia Sez Private Limited, buy the company report.
Financials of Eugia Sez Private Limited
FY 2025 filings availableEugia Sez Private Limited reported revenue of ₹383 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 10% growth in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹33.2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | -8.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eugia Sez Private Limited, buy the company report.
Board of directors of Eugia Sez Private Limited
Eugia Sez has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Mohan Reddy Mettu Also directs: MSS Packaging Industries LLP, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more | Director | 20 Feb 2021 | 5 Years 8 Months | Current |
| Vijay Natarajan | Director | 20 Feb 2021 | 5 Years 8 Months | Current |
| Mylandlahalli Rammohan Ashwini Also directs: Curateq Biologics Private Limited, Auro Vaccines Private Limited, Auroactive Pharma Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
| Santhanam Subramanian Also directs: Engenra Biologics Private Limited, Theranym Biologics Private Limited, Eugia Steriles Private Limited and 5 more | Director | 20 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Eugia Sez Private Limited is compared with the 5 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Marc Laboratories Limited | ₹383.21 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Pan Health & Hygiene Private Limited | ₹383.02 Cr (FY 2025) | 56.0% | Rajkot, Gujarat, India | |||
| Eugia Sez Private Limitedthis company | ₹383 Cr (FY 2025) | -₹33.2 Cr | -8.7% | 10.0% | 607 | Hyderabad, Telangana, India |
| Herbochem Industries Private Limited | ₹379.79 Cr (FY 2025) | -10.0% | Barabanki, Uttar Pradesh, India | |||
| Ica Pidilite Private Limited | ₹378.72 Cr (FY 2025) | -5.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Eugia Sez Private Limited, buy the company report.
Auditor
Eugia Sez Private Limited is audited by G P M & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M & Associates | FY 2024 | 015343S |
Shareholding
The shareholding of Eugia Sez Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Eugia Sez Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eugia Sez Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Eugia Sez Private Limited has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 16 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Eugia Sez Private Limited | |||
| Vinair Systems Private Limited | |||
| Evershine Tools Traders | |||
| Ami Polymer Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Eugia Sez Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Eugia Sez Private Limited has a workforce of 607 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 607 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Eugia Sez Private Limited, buy the company report.
GST
Eugia Sez has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCW8850H1ZZ | Telangana | Active | 13 Sep 2021 |
To see the full GST registrations and return filing status of Eugia Sez Private Limited, buy the company report.
Recent activity
Eugia Sez Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Mylandlahalli Rammohan Ashwini ceased to be Additional Director on 21 Jul 2024.
Frequently asked questions
Eugia Sez is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 February 2021 (5+ years old) and is registered under CIN U24299TG2021PTC148856.
Eugia Sez has 4 current directors:
- Madan Mohan Reddy Mettu - Director
- Vijay Natarajan - Director
- Mylandlahalli Rammohan Ashwini - Director
- Santhanam Subramanian - Director
The latest financial statements of Eugia Sez on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Eugia Sez is 36AACCW8850H1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Eugia Sez is U24299TG2021PTC148856. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eugia Sez was incorporated on 20 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Eugia Sez by revenue are Rajasthan Antibiotics Ltd, Marc Laboratories Limited, Pan Health & Hygiene Private Limited, Herbochem Industries Private Limited, Ica Pidilite Private Limited, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mylandlahalli Rammohan Ashwini ceased to be Additional Director on 21 Jul 2024. Mylandlahalli Rammohan Ashwini was appointed as Director on 14 May 2024. Sapna ceased to be Additional Director on 23 Jul 2023. Eugia Sez has 6 board changes on record in total.
Eugia Sez has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 16 overdue payments to 5 micro and small suppliers. The latest return was filed on 08 Dec 2023.
The registered office of Eugia Sez is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
Eugia Sez operates in the pharma industry, in the drug formulation and development segment.
Yes. Eugia Sez was formerly known as Wytells Pharma Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
